Angiocrine Bioscience, Inc.
Transforming medicine through cellular therapies that restore, regenerate, and repair tissues and organs
Funding history
About Angiocrine Bioscience, Inc.
How much funding has Angiocrine Bioscience, Inc. raised?
Angiocrine Bioscience, Inc. has raised $2.1M in total funding. The most recent round was Series A.
Where is Angiocrine Bioscience, Inc. headquartered?
Angiocrine Bioscience, Inc. is headquartered in San Diego, CA.
What does Angiocrine Bioscience, Inc. do?
Transforming medicine through cellular therapies that restore, regenerate, and repair tissues and organs
What's Angiocrine Bioscience, Inc.'s solution?
The page states Angiocrine develops 'E-CEL Therapies,' cellular therapies aimed at repairing tissue to help cure disease, but gives no further detail on the mechanism or target condition.
What makes Angiocrine Bioscience, Inc. notable?
Angiocrine Bioscience was founded by stem-cell researcher Dr. Shahin Rafii and has received funding from the California Institute for Regenerative Medicine (CIRM), the state's stem cell agency.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
